Silverarc Capital Management’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-882,300
| Closed | -$1.41M | – | 64 |
|
|
2025
Q1 | $1.41M | Sell |
882,300
-338,831
| -28% | -$542K | 0.29% | 52 |
|
|
2024
Q4 | $4.4M | Buy |
1,221,131
+73,240
| +6% | +$264K | 0.96% | 33 |
|
|
2024
Q3 | $6.54M | Sell |
1,147,891
-294,950
| -20% | -$1.68M | 1.47% | 22 |
|
|
2024
Q2 | $6.67M | Buy |
1,442,841
+6,910
| +0.5% | +$31.9K | 1.57% | 19 |
|
|
2024
Q1 | $11.7M | Buy |
+1,435,931
| New | +$11.7M | 3.26% | 9 |
|